Not only antiatherogenic and anti-inflammatory actions of statins have been associated with the activation of PPARα and γ ([119,120,121,122], but also cardioprotective statin effects, such as the inhibition of cardiac hypertrophy and fibrosis, can be attributed to PPARα and γ modulation [123,124,125]. Here, PPARA is linked to cardiac hypertrophy.